Mar 30, 2026 | Arbitration, Blog Post, Private Equity
A new analysis published in Health Affairs offers an early look at Q1-Q2 2025 data from the No Surprises Act’s federal Independent Dispute Resolution (IDR) process, finding that “the volume of cases submitted into the IDR process continues to exceed all expectations.”...
Mar 11, 2026 | Blog Post, Private Equity
Abuse and misuse of the No Surprises Act’s independent dispute resolution (IDR) process is fueling the health care affordability crisis. One reason? The decision-makers at the center of the IDR process — known as IDR entities, or IDREs — benefit from misaligned...
Feb 10, 2026 | Arbitration, Blog Post, Private Equity
When Congress passed the No Surprises Act, the goal was clear: protect patients from unexpected out-of-network medical bills. The law has largely succeeded in that regard, shielding patients from most surprise bills — especially large balance bills tied to emergency...
Jan 30, 2026 | Arbitration, Blog Post, Private Equity
The evidence of certain providers’ routine abuse and misuse of the No Surprises Act’s Independent Dispute Resolution (IDR) process, also known as arbitration, has been overwhelming. Recent lawsuits reveal repeated and persistent patterns of fraudulent IDR...
Jan 28, 2026 | Arbitration, Blog Post, Private Equity
The Centers for Medicare & Medicaid Services (CMS) just released new data from the first half of 2025 on the No Surprises Act’s Independent Dispute Resolution (IDR) process, and the numbers are staggering. Nearly 1.2 million disputes were filed in just six months,...
Jan 21, 2026 | Arbitration, Blog Post, Private Equity
It’s no surprise that private equity-backed providers—including Nutex Health—have co-opted the No Surprises Act’s (NSA) IDR process into their go-to profit center. It’s the reason why private equity-backed championed arbitration as their “solution” to the surprise...
Recent Comments